Cours PURE Bioscience, Inc. Other OTC
Actions
PURE
US74621T2096
Produits ménagers
CA 2022 | 1,85 M 1,66 M | CA 2023 | 1,88 M 1,68 M | Capitalisation | 9,51 M 8,53 M |
---|---|---|---|---|---|
Résultat net 2022 | -3 M -2,69 M | Résultat net 2023 | -3 M -2,69 M | VE / CA 2022 | 10,2 x |
Trésorerie nette 2022 | 3,39 M 3,04 M | Trésorerie nette 2023 | 74 k 66,4 k | VE / CA 2023 | 5,03 x |
PER 2022 |
-5,08
x | PER 2023 |
-2,39
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 59,55% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Robert Bartlett
CEO | Chief Executive Officer | 79 | 08/02/23 |
Mark Elliott
DFI | Director of Finance/CFO | 48 | 01/01/04 |
Dolana Blount
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/98 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Robert Bartlett
CEO | Chief Executive Officer | 79 | 08/02/23 |
Tom Myers
CTO | Chief Tech/Sci/R&D Officer | 71 | 09/05/11 |
Tom Lee
BRD | Director/Board Member | 75 | 24/10/14 |
Varia. 1 janv. | Capi. | |
---|---|---|
-20,92% | 38,21 Md | |
+12,07% | 26,06 Md | |
-13,60% | 6,82 Md | |
+1,60% | 5,78 Md | |
-8,04% | 2,9 Md | |
-2,64% | 2,2 Md | |
+2,55% | 2,07 Md | |
+22,31% | 914 M | |
+5,80% | 658 M |